These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32224496)

  • 1. Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress.
    Grounds MD; Terrill JR; Al-Mshhdani BA; Duong MN; Radley-Crabb HG; Arthur PG
    Dis Model Mech; 2020 Mar; 13(2):. PubMed ID: 32224496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophy.
    Iwasaki T; Terrill JR; Kawarai K; Miyata Y; Tagami T; Maeda N; Hasegawa Y; Watanabe T; Grounds MD; Arthur PG
    Acta Histochem; 2022 Dec; 124(8):151959. PubMed ID: 36270048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.
    Terrill JR; Al-Mshhdani BA; Duong MN; Wingate CD; Abbas Z; Baustista AP; Bettis AK; Balog-Alvarez CJ; Kornegay JN; Nghiem PP; Grounds MD; Arthur PG
    PLoS One; 2020; 15(10):e0240317. PubMed ID: 33031394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
    Apolinário LM; De Carvalho SC; Santo Neto H; Marques MJ
    Anat Rec (Hoboken); 2015 Sep; 298(9):1589-96. PubMed ID: 26011009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy.
    Segatto M; Szokoll R; Fittipaldi R; Bottino C; Nevi L; Mamchaoui K; Filippakopoulos P; Caretti G
    Nat Commun; 2020 Nov; 11(1):6108. PubMed ID: 33257646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway.
    Petrillo S; Pelosi L; Piemonte F; Travaglini L; Forcina L; Catteruccia M; Petrini S; Verardo M; D'Amico A; Musarò A; Bertini E
    Hum Mol Genet; 2017 Jul; 26(14):2781-2790. PubMed ID: 28472288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan.
    Kuraoka M; Aoki Y; Takeda S
    Exp Anim; 2021 Nov; 70(4):419-430. PubMed ID: 34135266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating markers of oxidative stress are associated with a muscle injury in patients with muscular dystrophy Duchenne.
    Almeida-Becerril T; Rodríguez-Cruz M; Raúl Sánchez-González J; Antonio Villaldama-Soriano M; Atilano-Miguel S; Villa-Morales J; Cárdenas-Conejo A; Cárdenas-Vázquez R
    Brain Dev; 2021 Jan; 43(1):111-120. PubMed ID: 32654955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Chu C; Balog-Alvarez C; Yu X; Cai JJ; Nabity M; Kornegay JN
    PLoS One; 2018; 13(3):e0194485. PubMed ID: 29554127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketogenic diet with medium-chain triglycerides restores skeletal muscle function and pathology in a rat model of Duchenne muscular dystrophy.
    Fujikura Y; Sugihara H; Hatakeyama M; Oishi K; Yamanouchi K
    FASEB J; 2021 Sep; 35(9):e21861. PubMed ID: 34416029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
    Terrill JR; Boyatzis A; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic
    Terrill JR; Bautista APR; Tsioutsias I; Grounds MD; Arthur PG
    Antioxidants (Basel); 2024 Jun; 13(6):. PubMed ID: 38929159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.